Evidence map›Paper›PMID 36580032›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation.

Simon Rothwell, Christopher I Amos, Frederick W Miller, Lisa G Rider, Ingrid E Lundberg, Peter K Gregersen, Jiri Vencovsky, Neil McHugh, Vidya Limaye, Albert Selva-O'Callaghan and 20 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. STAT4 gene polymorphisms in human diseases.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 13 countries.

Simon RothwellCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID 0000-0003-2123-9902
Christopher I AmosBaylor College of Medicine, Houston, Texas.
Frederick W MillerEnvironmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.ORCID 0000-0003-2831-9593
Lisa G RiderEnvironmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.ORCID 0000-0002-6912-2458
Ingrid E LundbergDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-6068-9212
Peter K GregersenThe Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institute, Manhasset, New York.
Jiri VencovskyInstitute of Rheumatology and Department of Rheumatology, First Medical Faculty, Charles University, Prague, Czech Republic.
Neil McHughDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Vidya LimayeRheumatology Unit, Royal Adelaide Hospital and Discipline of Medicine, Adelaide University, Adelaide, Australia.
Albert Selva-O'CallaghanInternal Medicine Department, Vall d'Hebron General Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-2823-9761
Michael G HannaDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.
Pedro M MachadoDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, and Centre for Rheumatology, UCL Division of Medicine, University College London, London, UK.ORCID 0000-0002-8411-7972
Lauren M PachmanAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Ann M ReedDepartment of Pediatrics, Duke University, Durham, North Carolina.ORCID 0000-0002-4521-7647
Øyvind MolbergDepartment of Rheumatology, Oslo University Hospital, Oslo, Norway.
Olivier BenvenisteDepartment of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Paris, France.
Pernille MathiesenPaediatric Department, Slagelse Hospital and Paediatric Rheumatology Unit, Rigshospitalet, Copenhagen, Denmark.
Timothy RadstakeDepartment of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
Andrea DoriaRheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0003-0548-4983
Jan L De BleeckerDepartment of Neurology, Ghent University, Ghent, Belgium.
Boel De PaepeDepartment of Neurology, Ghent University, Ghent, Belgium.ORCID 0000-0001-9403-4401
Britta MaurerDepartment of Rheumatology and Immunology, University Hospital, Bern, Switzerland.
William E OllierManchester Metropolitan University, School of Healthcare Sciences, Manchester, UK.
Leonid PadyukovDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Terrance P O'HanlonEnvironmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.
Annette LeeThe Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institute, Manhasset, New York.
Lucy R WedderburnNIHR Biomedical Research Centre at Great Ormond Street Hospital, and Arthritis Research UK Centre for Adolescent Rheumatology, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.ORCID 0000-0002-7495-1429
Hector ChinoyNational Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK, and Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK, and Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Janine A LambEpidemiology and Public Health Group, Division of Population Health, Health Services Research & Primary Care, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID 0000-0002-7248-0539
Myositis Genetics Consortium
National Institutes of Health · USFeinstein Institute for Medical Research · USGhent University Hospital · BEKarolinska University Hospital · SEManchester Academic Health Science Centre · GBBaylor College of Medicine · USCharles University · CZCopenhagen University Hospital · DKDuke University · USGreat Ormond Street Hospital · GBManchester Metropolitan University · GBNational Hospital for Neurology and Neurosurgery · GBNorthwestern University · USOslo University Hospital · NOQueen Mary University of London · GBRoyal Adelaide Hospital · AUSorbonne Université · FRUniversitat Autònoma de Barcelona · ESUniversity Hospital of Bern · CHUniversity Medical Center Utrecht · NL

Funding

Environmental/genetic Risk Factors and Pathogenesis of Autoimmune DiseaseZIAES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$34.6M
Intramural NIH HHS ZIA ES101074Medical Research Council MR/N003322/1Versus Arthritis 21552Versus Arthritis 21593Wellcome TrustWellcome Trust 085860
6 · The paper itself

Abstract

objectiveThe idiopathic inflammatory myopathies (IIMs) are heterogeneous diseases thought to be initiated by immune activation in genetically predisposed individuals. We imputed variants from the ImmunoChip array using a large reference panel to fine-map associations and identify novel associations in IIM.

methodsWe analyzed 2,565 Caucasian IIM patient samples collected through the Myositis Genetics Consortium (MYOGEN) and 10,260 ethnically matched control samples. We imputed 1,648,116 variants from the ImmunoChip array using the Haplotype Reference Consortium panel and conducted association analysis on IIM and clinical and serologic subgroups.

resultsThe HLA locus was consistently the most significantly associated region. Four non-HLA regions reached genome-wide significance, SDK2 and LINC00924 (both novel) and STAT4 in the whole IIM cohort, with evidence of independent variants in STAT4, and NAB1 in the polymyositis (PM) subgroup. We also found suggestive evidence of association with loci previously associated with other autoimmune rheumatic diseases (TEC and LTBR). We identified more significant associations than those previously reported in IIM for STAT4 and DGKQ in the total cohort, for NAB1 and FAM167A-BLK loci in PM, and for CCR5 in inclusion body myositis. We found enrichment of variants among DNase I hypersensitivity sites and histone marks associated with active transcription within blood cells.

conclusionWe found novel and strong associations in IIM and PM and localized signals to single genes and immune cell types.

Indexed as

Autoimmune DiseasesMyositisPolymyositisGenetic Predisposition to DiseaseHaplotypesHumans

Identifiers

PMID36580032
PMCPMC10238560
OpenAlexW4313279535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.